Clinical trial

Therapeutic Effects of Berberine in Patients With Type 2 Diabetes

NCT00425009 · Shanghai Jiao Tong University School of Medicine, Other · Completed

Key facts

NCT number NCT00425009
Title Therapeutic Effects of Berberine in Patients With Type 2 Diabetes
Official title Effects of Berberine on Improvement of Glucose and Lipid Metabolism in Patients With Type 2 Diabetes
Lead sponsor Shanghai Jiao Tong University School of Medicine, Other
Collaborators National Institutes of Health (NIH) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Type 2 Diabetes
Intervention type Drug
Interventions Berberine, Metformin
Enrollment 70
Start date Jan 1, 2004
Completion Dec 1, 2004
First posted Jan 22, 2007
Last update posted Jan 22, 2007
Countries China

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies